Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
RAPS Convergence is going virtual. Join the brightest minds in regulatory online to gain the latest knowledge in the field in an all-virtual experience with workshops, one-on-one expert sessions, and networking communities.
This year, our European regulatory community will converge online with a fully virtual program that will allow attendees to experience Euro Convergence live online from the safety and comfort of their homes.
RAPS' “how to” guide to developing a comprehensive global regulatory strategy for all types of medical devices. Updated September 2020.
The last exam window of 2020 is currently open. Register by 8 October to take the RAC exam this autumn.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.
Posted 27 April 2012 | By Alexander Gaffney, RAC
Regulatory Focus and other media outlets reported on 24 April about China's crackdown on counterfeit medications, which found dozens of manufacturing facilities using industrial-grade gelatin in pharmaceutical capsules. Now Chinese authorities have found something else that is perhaps even more surprising: a small river filled with millions of discarded drug capsules.
Gizmodo reports 300 meters of an open sewer ditch were transformed overnight into a "rainbow river," the victim of an illegal dumping operation involving millions of dyed capsules.
The water source, located in Zhengzhou, China, is reportedly not close to any pharmaceutical manufacturers, leading some to think an unknown lab may have gotten spooked after Chinese authorities started cracking down on manufacturers several weeks ago.
Reuters reported on 24 April that the Ministry of Public Security had arrested 9 people, detained another 45 and seized 77 million capsules laced with chromium-a heavy metal linked to cancer concerns. Those capsules were seized in the Zhejiang, Hebei and Jiangxi provinces of China.
Read more: (And see the stunning photos)
Gizmodo - Mysterious Rainbow River of Pills Appears In China
China Smack - 'Rainbow River': Unused Medicine Capsules Dumped in Henan Ditch
Regulatory Focus - China Probe Into Chromium-Laced Capsules Escalates, 77M Capsules Seized
Tags: Dumping, Pills, River, Capsules, Chromium, Counterfeit, Latest News, pharmaceutical, drug
Regulatory Focus newsletters
All the biggest regulatory news and happenings.